Health ❯ Healthcare

Medications

Weight Loss Weight Loss Drugs GLP-1 Drugs Side Effects Weight Management GLP-1 Agonists Diabetes GLP-1 Weight Loss Medications GLP-1 Receptor Agonists

Ashley Graham Calls GLP-1 Weight-Loss Craze a 'Smack in the Face' to Body Positivity

Her remarks spotlight a clash over weight-loss shots versus recent gains for body acceptance.

Study Links GLP-1 Weight-Loss Drugs to Hair Shedding With Rapid Weight Loss

Lancet Trial Finds Semaglutide Sharply Reduces Heavy Drinking in Patients With Obesity

Lilly’s Foundayo Start Trails Wegovy as Street Stays Positive

Boehringer’s Dual-Agonist Survodutide Cuts Body Weight by Up to 16.6% in Phase III Trial

New Data Tie GLP-1 Drugs’ Broad Benefits to Inflammation

Teddi Mellencamp Says Doctor Denied GLP-1 Weight-Loss Drugs During Cancer Treatment

Trial Hints ‘Gut Reset’ May Slow Weight Regain After Stopping GLP‑1 Drugs

CMS Pauses Medicare GLP-1 Pilot After Insurers Balk, Sets 2026–27 Bridge

Triple Low-Dose Pill Cuts Repeat Brain-Bleed Strokes by 39%, NEJM Trial Finds

Xenon Presents Phase 3 Azetukalner Results and 48‑Month Data at American Academy of Neurology Meeting

Viatris Recalls One Lot of Xanax XR Nationwide After Tablets Fail FDA Dissolution Test

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

Amazon Pharmacy Launches Same-Day Delivery for Lilly’s Foundayo Weight-Loss Pill

Mexico Renews Warning as Counterfeit GLP-1 Weight-Loss Drugs Spread Worldwide

FDA Clears Eli Lilly’s Foundayo Oral GLP-1 for Weight Loss, With U.S. Launch Set for April 6

Germany to Cover Four Off-Label Drugs for Long Covid Under Statutory Insurance

FDA Grants Accelerated Approval to Lilly’s Oral Weight-Loss Pill Foundayo

India Tightens Oversight of GLP-1 Diabetes and Weight-Loss Drugs

Martin Lewis Urges Shoppers To Check PL Codes To Cut Medicine Costs